Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: China Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20091
20113
20122
20134
20141
20151
20162
20172
20184
20193
20201
20216
20223
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Unknown status10
Recruiting6
Not yet recruiting2
Active, not recruiting2
Withdrawn1
Enrolling by invitation1
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Bristol-Myers Squibb4
Shenzhen TargetRx Co., Ltd.4
Nanfang Hospital, Southern Medical University3
Pfizer3
Ascentage Pharma Group Inc.2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Jiangsu Hansoh Pharmaceutical Co., Ltd.2
iCell Gene Therapeutics2
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive45
Leukemia6
Myeloproliferative Disorders4
Philadelphia Chromosome4
Bronchiolitis Obliterans Syndrome3
Leukemia, Myeloid, Acute3
Leukemia, Myeloid, Chronic-Phase3
Myelodysplastic Syndromes3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Hematologic Neoplasms2

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.